Related Experiment Video
Updated: May 9, 2026
06:40
The Dyspepsia Educational Tool As a Novel Aid in Dyspepsia Management
Published on: June 29, 2019
Technology Update: An Overview of PDA-Based Software Applications for Practicing Pharmacists.
Nikhil G Khandelwal1, Bill G Felkey
1Pharmacy Care Systems, Auburn University, Harrison School of Pharmacy, Auburn, Alabama.
International Journal of Pharmaceutical Compounding
|August 9, 2013
Summary
Pharmacists face challenges selecting personal digital assistant (PDA) devices and clinical software. This guide highlights essential PDA applications for community pharmacy practice.
Area of Science:
- Health Informatics
- Pharmacy Practice
- Mobile Technology Adoption
Background:
- Healthcare professionals, including pharmacists, experience difficulty choosing appropriate personal digital assistant (PDA) hardware and software.
- Selecting suitable clinical applications for PDAs is a significant challenge for daily practice.
Purpose of the Study:
- To provide an overview of essential personal digital assistant (PDA)-based clinical software applications.
- To guide practicing pharmacists in community settings on relevant PDA software selection.
Main Methods:
- Literature review of PDA clinical applications relevant to pharmacy.
- Analysis of software features and their utility in community pharmacy.
Main Results:
- Identification of key PDA software categories crucial for pharmacists.
- Discussion of the importance and relevance of specific clinical applications.
Conclusions:
- Personal digital assistant (PDA) technology offers valuable tools for community pharmacists.
- Informed selection of PDA clinical applications can enhance pharmacy practice.
Related Concept Videos
01:27Pharmacodynamic Models: Overview
Pharmacodynamic (PD) responses describe the interaction between a drug and its biological target, culminating in a physiological effect. These responses can be classified into different types: continuous variables, such as blood glucose levels; categorical outcomes, like survival rates; and time-to-event metrics, such as disease progression. Understanding and modeling PD responses are critical for optimizing drug efficacy and safety.PD models describe the relationship between drug concentration...
01:26Drug Administration and Therapy Phases: Overview
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
01:19Modified-Release Drug Delivery Systems: Overview
Modified-release dosage forms are designed to address the limitations of drugs with short biological half-lives. These forms maintain stable therapeutic drug concentrations over extended periods, reducing the need for frequent dosing. A consistent drug level helps minimize peak-trough fluctuations, which can reduce adverse effects, lower the risk of drug resistance, and improve overall treatment effectiveness.One common type of modified-release form is the extended-release (ER) formulation. ER...
01:24Pharmacokinetic–Pharmacodynamic Relationship: Problems
The empirical approach to drug therapy optimization relies on correlating pharmacological response with administered dosage. Such an approach can be costly, time-consuming, and often yields poor correlation due to variables like formulation factors and drug elimination characteristics. A more precise approach correlates response with plasma drug concentration or the amount of drug in the body, rather than dosage. This is achieved through pharmacokinetic-pharmacodynamic (PK/PD) modeling, which...
01:28Dosage Regimens: Designs and Approaches
Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...
00:59Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis
Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This relationship...
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This relationship...